drugset / Trial / NCT00739960
Safety Study of Abatacept to Treat Refractory Sarcoidosis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine how safe and effective Abatacept is in treating patients who have progressive pulmonary sarcoidosis.
Timeline
- Start
- 2008-08
- Primary completion
- 2008-12
- Completion
- 2008-12
Outcome
Outcome not reported
Stopped (Business): “Funding has been pulled”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abatacept | Other / unclassified | 10 mg/kg | Intravenous |